Long-Term Administration of Multikinase Inhibitors Is a Potential Risk Factor for Atherosclerosis in Patients with Thyroid Cancer
MKI administration may be an independent risk factor for atherosclerosis in patients with thyroid cancer. Complications associated with atherosclerotic disease should be monitored during long-term MKI administration.
Authors
- Tomoya Yokota (ORCID: https://orcid.org/0000-0001-7327-7949)
- Nao Muraoka (ORCID: https://orcid.org/0009-0007-3564-039X)
- Satoshi Hamauchi (ORCID: https://orcid.org/0000-0002-9857-2095)
- Kei Iida (ORCID: https://orcid.org/0000-0001-7130-8705)
- Takeshi Kawakami (ORCID: https://orcid.org/0000-0001-9385-9516)
- Takuya Oyakawa (ORCID: https://orcid.org/0000-0001-7637-5501)
- Ayano Fujita
Institutions
- Taoka Hospital (JP)
- Shizuoka Cancer Center (JP)
Publication Details
- Journal
- Cardiology
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1159/000549932
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00